---
title: "Erlotinib - Non-small cell lung cancer"
sidebar: mydoc_sidebar
permalink: db00530-mesh-d002289-1.html
toc: false 
---


Path ID: `DB00530_MESH_D002289_1`
{% include image.html url="images/db00530-mesh-d002289-1.png" file="db00530-mesh-d002289-1.png" alt="db00530-mesh-d002289-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069347 | erlotinib | Drug |
| UniProt:P00533 | Epidermal growth factor receptor | Protein |
| REACT:R-HSA-5673001 | RAF/MAP kinase cascade | Pathway |
| REACT:R-HSA-109704 | PI3K Cascade | Pathway |
| GO:0008283 | Cell proliferation | BiologicalProcess |
| MESH:D002289 | Non-small cell lung cancer | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Erlotinib | DECREASES ACTIVITY OF | Epidermal Growth Factor Receptor |
| Epidermal Growth Factor Receptor | POSITIVELY REGULATES | Raf/Map Kinase Cascade |
| Epidermal Growth Factor Receptor | POSITIVELY REGULATES | Pi3K Cascade |
| Raf/Map Kinase Cascade | POSITIVELY REGULATES | Cell Proliferation |
| Pi3K Cascade | POSITIVELY REGULATES | Cell Proliferation |
| Cell Proliferation | CAUSES | Non-Small Cell Lung Cancer |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00530#mechanism-of-action](https://go.drugbank.com/drugs/DB00530#mechanism-of-action){:target="_blank"}